References
- Baum H., Davies H., Peakman M. Molecular mimicry in the MHC: hidden clues to autoimmunity. Immunol. Today 1976; 17: 64–70
- Czaja A. J., Carpenter H. A., Santrach P. J., Moore S. B. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 1993; 105: 1502–1507
- Ota M., Seki T., Kiyosawa K., Furuta S., Hino K., Kondo T., et al. A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis. Immunogenelics 1992; 36: 49–55
- Seki T., Ota M., Furuta S., Fukushima H., Kondo T., Hino K., et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992; 103: 1041–1047
- Manabe K., Donaldson P. T., Underhill J. A., Doherty D. G., Mieli-Vergani G., McFarlane I. G., et al. Human leukocyte antigen A1-B8-DR3-DQ2-DPB 1*0401 extended haplotype in autoimmune hepatitis. Hepatology 1993; 18: 1334–1337
- Treichel U., Poralla T., Hess G., Manns M., Meyer zum Buschen-Feldt H. K.-. Autoantibodies to human asialoglycoprotein receptor (ASGPR) in autoimmune-type chronic hepatitis. Hepatology 1990; 11: 606–612
- Jendro M., Goronzy J. J., Weyand M. C. Structural and functional characterization of HLA-DR molecules circulating in the serum. Autoimmunity 1991; 8: 289–296
- Westhoff U., Thiness F. P., Gotz H., Grosse-Wilde H. Quantification of soluble HLA class 11 molecules by an enzyme-linked immunosorbent assay. Vox Sang 1991; 61: 106–110
- Herlyn M., Lange B., Bennicelli J., Blaszczyk M. D., Guerry I V, Koprowski H. Increased levels of circulation HLA-DR antigen in sera of patients with acute lymphoblastoid leukemia. Leuk. Res 1984; 8: 323–334
- Filaci G., Contini P., Brenci S., Lanza L., Scudeletti M., Indiveri F., et al. Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. Tissue Antigens 1995; 46: 117–123
- Shimura T., Hagihara M., Yamamoto K., Takebe K., Munkhbat B., Tsuji K. Quantification of soluble forms of HLA in kidney transplantation. Transplant Proc 1994; 26, 1981
- Weyand M. C, Jendro M., Goronzy J. J. Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders. Autoimmunity 1991; 8: 281–287
- Barbatis C., Kelly P., Greveson J., Heryet A., Jo'dmcgee. Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man. J. Clin. Pathol 1987; 40: 879–884
- Senaldi G., Portmann B., Mowat A. P., Mieli-Vergani G., Vergani D. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch. Dis. Child 1992; 67: 1447–1453
- Danque P. O.V., Bach N., Schaffner F., Gerber M. A., Thung S. N. HLA-DR expression in bile duct damage in hepatitis C. Mod. Pathol 1993; 6: 327–331
- Spengler U., Pape G. R., Hoffmann R. M., Johnson J. P., Eisenburg J., Paumgartner G., et al. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology 1988; 8: 459–462
- Haga J. A., She J. X., Kao K. J. Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma. J. Biol. Chem 1991; 266: 3695–3701
- Kubens B. S., PaBler M., Grosse-Wilde H. Segregation study of the soluble 39-kD HLA class I heavy chain. Human Immunol 1994; 40: 247–252
- Johnson P. J., McFarlane I. G. Farlane. Meeting report: International autoimmune hepatitis group Hepatology. 1993; 18: 998–1005
- Steinman R. M., Witmer-Pack, lnaba K. Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv. Exp. Med. Biol 1993; 329: 1–9
- Zavazava N., Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 1996; 2: 1005–1010
- Nag B., Kendrick T., Arimilli S., Yu S. C.T., Sriram S. Soluble MHC Il-peptide complexes induce antigen-specific apoptosis in T cells. Cell Immunol 1996; 170: 25–33